ZIMLAB

Zim Laboratories Share Price

 

 

Start SIP in ZIMLAB

Start SIP
Zim Laboratories live price: ₹63.46. It opened at ₹63 vs previous close ₹64; intraday high/low: ₹67/₹60. The 50 & 200 DMA stand at ₹68.92/₹77.44.

Zim Laboratories Performance

  • Today's Low
  • ₹60
  • Today's High
  • ₹67
  • 52 Week Low
  • ₹60
  • 52 Week High
  • ₹127
  • Open Price₹63
  • Previous Close₹64
  • Volume143,542
  • 50 DMA₹68.92
  • 100 DMA₹71.61
  • 200 DMA₹77.44

Investment Returns

  • Over 1 Month -9.91%
  • Over 3 Month -7.48%
  • Over 6 Month -13.34%
  • Over 1 Year -24.46%

Smart Investing Starts Here Start SIP with Zim Laboratories for Steady Growth!

Invest Now

Zim Laboratories Fundamentals Fundamentals refer to the financial data that companies report on a quarterly or annual basis.

  • P/E Ratio
  • 48.6
  • PEG Ratio
  • -0.9
  • Market Cap Cr
  • 340
  • P/B Ratio
  • 1.3
  • Average True Range
  • 4.37
  • EPS
  • 1.31
  • Dividend Yield
  • 0
  • MACD Signal
  • -1.55
  • RSI
  • 42.3
  • MFI
  • 46.91

Zim Laboratories Financials

Zim Laboratories Technicals

EMA & SMA

Current Price
₹63.46
-0.29 (-0.45%)
pointer
  • Bearish Moving Average 16
  • Bullish Moving Average 0
  • 20 Day
  • ₹66.49
  • 50 Day
  • ₹68.92
  • 100 Day
  • ₹71.61
  • 200 Day
  • ₹77.44

Resistance and Support

63.55 Pivot Speed
  • R3 72.87
  • R2 69.79
  • R1 66.63
  • S1 60.39
  • S2 57.31
  • S3 54.15

Ratings

Master Rating

EPS Strenth

Price Strength

Buyer Demand

Group Rank

Zim Laboratories has an operating revenue of Rs. 377.86 Cr. on a trailing 12-month basis. An annual revenue growth of 3% is not great, Pre-tax margin of 5% is okay, ROE of 4% is fair but needs improvement. The company has a reasonable debt to equity of 16%, which signals a healthy balance sheet. The stock from a technical standpoint is trading below to its key moving averages. It needs to take out these levels and stay above it to make any meaningful move. From an O'Neil Methodology perspective, the stock has an EPS Rank of 29 which is a POOR score indicating inconsistency in earnings, a RS Rating of 42 which is POOR indicating the underperformance as compared to other stocks, Buyer Demand at D+ which indicates heavy supply, Group Rank of 23 indicates it belongs to a strong industry group of Medical-Generic Drugs and a Master Score of D is close to being the worst. Overall, the stock has poor technical strength and poor fundamentals, there are superior stocks in the current market environment.

Disclaimer: This stock analysis report is algorithmically generated for informational purposes only and should not be considered as a buy or sell recommendation.

View More

Zim Laboratories Corporate Actions - Bonus, Splits, Dividends

Date Purpose Remarks
2026-02-11 Quarterly Results
2026-01-21 Others
2025-11-12 Quarterly Results
2025-08-07 Quarterly Results
2025-05-20 Audited Results
Date Purpose Remarks
2022-12-22 Bonus Rs.0.00 issue in the ratio of 2:1 of Rs. 10/-

Zim Laboratories F&O

Zim Laboratories Shareholding Pattern

30.3%
0%
32.81%
36.89%

Zim Laboratories FAQs

Zim Laboratories share price is ₹63 As on 28 March, 2026 | 05:56

The Market Cap of Zim Laboratories is ₹339.5 Cr As on 28 March, 2026 | 05:56

The P/E ratio of Zim Laboratories is 48.6 As on 28 March, 2026 | 05:56

The PB ratio of Zim Laboratories is 1.3 As on 28 March, 2026 | 05:56

Open Free Demat Account

Be a part of 5paisa community - The first listed discount broker of India.

+91

By proceeding, you agree to all T&C*

footer_form

Disclaimer: Investment in securities market are subject to market risks, read all the related documents carefully before investing. For detailed disclaimer please Click here.

Q2FY23